Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Why Herbal Dispatch (CSE:HERB) Is Getting Attention (click to learn more) Atlas Salt Expands MOU with Sandvik Mining Supporting Great Atlantic Salt Project (click to learn more) Digital Health Meets AI -CSE: ALEN.U (click to learn more) New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Vyne Therapeutics Inc VYNE

Healthcare Biotechnology
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company’s lead program is repibresib gel (VYN201), a topically administered small molecule pan-bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple and diverse inflammatory cell signaling... see more

Current News (NDAQ:VYNE)

Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire December 20, 2025

VYNE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of VYNE Therapeutics Inc. is Fair to Shareholders

Business Wire December 17, 2025

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement 

GlobeNewswire December 17, 2025

VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update

GlobeNewswire November 6, 2025

VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update

GlobeNewswire August 14, 2025

VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo

GlobeNewswire July 30, 2025

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

GlobeNewswire July 2, 2025

VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update

GlobeNewswire May 8, 2025

VYNE Therapeutics Provides Update on VYN202 Program

GlobeNewswire April 25, 2025
View More News ››

Opinion & Analysis (NDAQ:VYNE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VYNE)

VYNE Therapeutics Inc. (NASDAQ:VYNE): Unlocking the Potentia

http://beyondspx.com/2024/07/31/vyne-therapeutics-inc-nasdaqvyne-unlocking-the-potential-of-bet-inhibition-in-immuno-inflammatory...
MikeTester - August 2, 2024

VYNE......no volume

Just a big "nothing burger"
Iseneschal - February 15, 2023

VYNE...... NR

On watch at $4 No position
Iseneschal - February 15, 2023
View more Bullboard ››

Sky Gold Corp.

Sky Gold Corp.

Sky Gold Corp., a junior mineral exploration company, engages in the exploration and development of mineral properties in ...
View More »

Podcasts